Biocatalytic Routes to Optically Active Amines

Optically active amines and amino acids play an important role in the pharmaceutical, agrochemical, and chemical industries. They are frequently used as synthons for the preparation of various pharmaceutically active substances and agrochemicals, but also as resolving agents to obtain chiral carboxylic acids. Consequently, there is a need for efficient methods to obtain the desired enantiomer of a given target structure in optically pure form. Beside a range of chemical methods using for example, asymmetric synthesis with transition metal catalysts, enzymes represent a useful alternative to access this important class of compounds. This review covers biocatalytic approaches using hydrolases (i.e. lipases, amidases), monoamine oxidase and other enzymes. Special focus is given on the application of ω‐transaminases with emphasis on concepts to allow efficient asymmetric synthesis starting from prostereogenic ketones.

[1]  U. Bornscheuer,et al.  A Protection Strategy Substantially Enhances Rate and Enantioselectivity in ω‐Transaminase‐Catalyzed Kinetic Resolutions , 2008 .

[2]  Jeffrey C. Moore,et al.  Rapid screening and scale-up of transaminase catalysed reactions. , 2009, Organic & biomolecular chemistry.

[3]  N. Vanthuyne,et al.  Dynamic kinetic resolution of amines involving biocatalysis and in situ free radical mediated racemization. , 2007, Organic letters.

[4]  L. Ingram,et al.  Cloning and Characterization of the Zymobacter palmae Pyruvate Decarboxylase Gene (pdc) and Comparison to Bacterial Homologues , 2002, Applied and Environmental Microbiology.

[5]  J. Shin,et al.  Exploring the active site of amine:pyruvate aminotransferase on the basis of the substrate structure-reactivity relationship: how the enzyme controls substrate specificity and stereoselectivity. , 2002, The Journal of organic chemistry.

[6]  Seongyop Lim,et al.  ω-Amino Acid:Pyruvate Transaminase from Alcaligenes denitrificans Y2k-2: a New Catalyst for Kinetic Resolution of β-Amino Acids and Amines , 2004, Applied and Environmental Microbiology.

[7]  Jaiwook Park,et al.  Dynamic kinetic resolution of primary amines with a recyclable Pd nanocatalyst for racemization. , 2007, Organic letters.

[8]  Y. Koyama,et al.  Total synthesis of a protected aglycon of the kedarcidin chromophore. , 2009, Angewandte Chemie.

[9]  R. Silverman,et al.  Design of potential anticonvulsant agents: mechanistic classification of GABA aminotransferase inactivators. , 1989, Journal of medicinal chemistry.

[10]  Friedhelm Balkenhohl,et al.  Optisch aktive Amine durch Lipase-katalysierte Methoxyacetylierung† , 1997 .

[11]  R. Mohanty,et al.  Asymmetric Reductive Amination: Convenient Access to Enantioenriched Alkyl‐Alkyl or Aryl‐Alkyl Substituted α‐Chiral Primary Amines , 2006 .

[12]  Nicholas J Turner,et al.  Directed evolution of an amine oxidase possessing both broad substrate specificity and high enantioselectivity. , 2003, Angewandte Chemie.

[13]  Byung-Kwan Cho,et al.  Kinetic resolution of (R,S)‐sec‐butylamine using omega‐transaminase from Vibrio fluvialis JS17 under reduced pressure , 2004, Biotechnology and bioengineering.

[14]  J. Bäckvall,et al.  Chemoenzymatic dynamic kinetic resolution of primary amines. , 2005, Journal of the American Chemical Society.

[15]  Christian Wandrey,et al.  Industrial Biotransformations: LIESE: INDUSTRIAL BIOTRANSFORMATIONS O-BK , 2006 .

[16]  S. Ōmura,et al.  Structure determination and total synthesis of bottromycin A2: a potent antibiotic against MRSA and VRE. , 2009, Angewandte Chemie.

[17]  Nicholas J Turner,et al.  Directed Evolution of an Amine Oxidase for the Preparative Deracemisation of Cyclic Secondary Amines , 2005, Chembiochem : a European journal of chemical biology.

[18]  P. Abrams,et al.  A dose‐ranging study of the efficacy and safety of tamsulosin, the first prostate‐selective a1A‐adrenoceptor antagonist*, in patients with benign prostatic obstruction , 1997 .

[19]  Mark E. B. Smith,et al.  Substrate spectrum of ω-transaminase from Chromobacterium violaceum DSM30191 and its potential for biocatalysis , 2007 .

[20]  J. Michael.  Indolizidine and quinolizidine alkaloids. , 2007, Natural product reports.

[21]  J. Shin,et al.  Kinetic resolution of α-methylbenzylamine with ο-transaminase screened from soil microorganisms: Application of a biphasic system to overcome product inhibition , 1997 .

[22]  G. Bringmann,et al.  Acetogenic Isoquinoline Alkaloids, L. The Synthesis of All Possible Isomeric 6,8‐Dioxygenated 1,3‐Dimethyl‐1,2,3,4‐tetrahydroisoquinoline Methyl Ethers – Useful Chiral Building Blocks for Naphthylisoquinoline Alkaloids , 1993 .

[23]  B Hauer,et al.  Continuous production of (R)-phenylacetylcarbinol in an enzyme-membrane reactor using a potent mutant of pyruvate decarboxylase from Zymomonas mobilis. , 2001, Biotechnology and bioengineering.

[24]  G. Matcham,et al.  Biocatalysis for chiral intermediates : Meeting commercial and technical challenges , 1996 .

[25]  Wolfgang Kroutil,et al.  New enzymes for biotransformations. , 2005, Current opinion in chemical biology.

[26]  N. Itoh,et al.  Determining a novel NAD+-dependent amine dehydrogenase with a broad substrate range from Streptomyces virginiae IFO 12827: purification and characterization , 2000 .

[27]  Xumu Zhang,et al.  Developing chiral ligands for asymmetric hydrogenation. , 2007, Accounts of chemical research.

[28]  Juhan Kim,et al.  Synthesis of enantiomerically pure trans-(1R,2R)- and cis-(1S,2R)-1-amino-2-indanol by lipase and omega-transaminase. , 2006, Biotechnology and bioengineering.

[29]  G. Friestad.  Chiral N‐Acylhydrazones: Versatile Imino Acceptors for Asymmetric Amine Synthesis , 2005 .

[30]  D. Anderson.  Sitafloxacin hydrate for bacterial infections. , 2008, Drugs of today.

[31]  N. Vanthuyne,et al.  Thiyl radical mediated racemization of benzylic amines , 2006 .

[32]  Yinjun Zhang,et al.  An amine: hydroxyacetone aminotransferase from Moraxella lacunata WZ34 for alaninol synthesis , 2008, Bioprocess and biosystems engineering.

[33]  D. Shonnard,et al.  Improved activity and thermostability of (S)-aminotransferase by error-prone polymerase chain reaction for the production of a chiral amine , 2007 .

[34]  J. Ellman,et al.  Applications of tert-butanesulfinamide in the asymmetric synthesis of amines , 2003 .

[35]  Y. Ikenaka,et al.  Microbial synthesis of (R)- and (S)-3,4-dimethoxyamphetamines through stereoselective transamination , 2003, Biotechnology Letters.

[36]  Q. Xie,et al.  5‐Chloro‐7‐iodo‐8‐quinolinolatomanganese(III) with the Feature of pH‐Regulated Molecular Switches as a Highly Efficient Catalyst for Epoxidation of Olefins with Hydrogen Peroxide , 2008 .

[37]  Byung Gee Kim,et al.  Asymmetric synthesis of chiral amines with ω‐transaminase , 1999 .

[38]  N. Vanthuyne,et al.  Thiyl radical mediated racemization of nonactivated aliphatic amines. , 2006, The Journal of organic chemistry.

[39]  Bernhard Hauer,et al.  Industrial methods for the production of optically active intermediates. , 2004, Angewandte Chemie.

[40]  Takao Saito,et al.  Developments in asymmetric hydrogenation from an industrial perspective. , 2007, Accounts of chemical research.

[41]  M. Yasuda,et al.  Purification and crystallization of bacterial ω‐amino acid‐pyruvate aminotransferase , 1976 .

[42]  Juhan Kim,et al.  Cloning and Characterization of a Novel β-Transaminase from Mesorhizobium sp. Strain LUK: a New Biocatalyst for the Synthesis of Enantiomerically Pure β-Amino Acids , 2007, Applied and Environmental Microbiology.

[43]  Rainer Stürmer,et al.  Industrielle Verfahren zur Herstellung von optisch aktiven Zwischenprodukten , 2004 .

[44]  J. Shin,et al.  Substrate inhibition mode of omega-transaminase from Vibrio fluvialis JS17 is dependent on the chirality of substrate. , 2002, Biotechnology and bioengineering.

[45]  Byung Gee Kim,et al.  Kinetic resolution of chiral amines with ω‐transaminase using an enzyme‐membrane reactor , 2001 .

[46]  Ramesh N. Patel,et al.  Preparation of (R)-Amines from Racemic Amines with an (S)-Amine Transaminase from Bacillus megaterium , 2008 .

[47]  Meredith Williams,et al.  Oxazolones as potent inhibitors of 11beta-hydroxysteroid dehydrogenase type 1. , 2007, Bioorganic & medicinal chemistry letters.

[48]  Nicholas J Turner,et al.  The structure of monoamine oxidase from Aspergillus niger provides a molecular context for improvements in activity obtained by directed evolution. , 2008, Journal of molecular biology.

[49]  J. Clardy,et al.  Korupensamines A-D, Novel Antimalarial Alkaloids from Ancistrocladus korupensis , 1994 .

[50]  Wolfgang Kroutil,et al.  Asymmetric Synthesis of Optically Pure Pharmacologically Relevant Amines Employing ω‐Transaminases , 2008 .

[51]  J. Stewart.  Dehydrogenases and transaminases in asymmetric synthesis. , 2001, Current opinion in chemical biology.

[52]  G. Friestad,et al.  Recent developments in asymmetric catalytic addition to CN bonds , 2007 .

[53]  Miss A.O. Penney.  (b) , 1974, The New Yale Book of Quotations.

[54]  B. Pugin,et al.  Solvias Josiphos Ligands: From Discovery to Technical Applications , 2002 .

[55]  Yangsoo Ahn,et al.  Racemization catalysts for the dynamic kinetic resolution of alcohols and amines , 2008 .

[56]  G. Guebitz,et al.  Formal asymmetric biocatalytic reductive amination. , 2008, Angewandte Chemie.

[57]  W. Kroutil,et al.  Deracemisation of α‐Chiral Primary Amines by a One‐Pot, Two‐Step Cascade Reaction Catalysed by ω‐Transaminases , 2009 .

[58]  A. Kuboki,et al.  Improved Enzymatic Procedure for a Preparative-Scale Synthesis of Sialic Acid and KDN. , 1995 .

[59]  Karen Robins,et al.  Efficient Asymmetric Synthesis of Chiral Amines by Combining Transaminase and Pyruvate Decarboxylase , 2008, Chembiochem : a European journal of chemical biology.

[60]  T. Hoye,et al.  Total synthesis of (ent)-korupensamine D , 1996 .

[61]  Masakazu Atobe,et al.  Enantioselective synthesis of primary 1-(aryl)alkylamines by nucleophilic 1,2-addition of organolithium reagents to hydroxyoxime ethers and application to asymmetric synthesis of G-protein-coupled receptor ligands. , 2004, The Journal of organic chemistry.

[62]  H. Blaser,et al.  The Highly Enantioselective Hydrogenation of N‐Diphenylphosphinylketimines with Cationic Rh Ferrocenyldiphosphine Catalysts , 2001 .

[63]  Nicholas J Turner,et al.  Efficient kinetic resolution of racemic amines using a transaminase in combination with an amino acid oxidase. , 2009, Chemical communications.

[64]  M. Reetz,et al.  Lipase-Catalyzed Dynamic Kinetic Resolution of Chiral Amines: Use of Palladium as the Racemization Catalyst , 1996, CHIMIA.

[65]  K. Horiike,et al.  Crystallization and properties of aromatic amine dehydrogenase from Pseudomonas sp. , 1983, Archives of biochemistry and biophysics.

[66]  Uwe T. Bornscheuer,et al.  Biocatalytic Routes to Optically Active Amines , 2009 .

[67]  B. Hwang,et al.  Identification of ω-aminotransferase from Caulobacter crescentus and site-directed mutagenesis to broaden substrate specificity. , 2008, Journal of microbiology and biotechnology.

[68]  Jieping Zhu,et al.  Synthetic studies toward ecteinascidin 743. , 2005, The Journal of organic chemistry.

[69]  A. Chadha,et al.  Asymmetric reduction of aryl imines using Candida parapsilosis ATCC 7330 , 2008 .

[70]  Juhan Kim,et al.  Redesigning the substrate specificity of ω‐aminotransferase for the kinetic resolution of aliphatic chiral amines , 2008, Biotechnology and bioengineering.

[71]  J. Shin,et al.  Comparison of the ω-Transaminases from Different Microorganisms and Application to Production of Chiral Amines , 2001, Bioscience, biotechnology, and biochemistry.

[72]  Y. Agid,et al.  Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trialCommentary: Another piece of the Alzheimer's jigsaw , 1999 .